High circulating [38] and SF levels of (MCP-1)/CCL2 have been observed in RA, PsA and SpA patients [34,39,40] and were also associated to the response to etanercept in RA patients [41]. The gene discussed is CCL2; the disease is rheumatoid arthritis.